Artelo Biosciences- Warrants (18/06/2024) Return on Equity

Artelo Biosciences- Warrants (18/06/2024) (ARTLW) currently reports a ROE of -201.81%. That is below the Consumer Staples sector average of 14.41%. Use the charts on this page to explore Artelo Biosciences- Warrants (18/06/2024)'s ROE history and peer comparisons.

Artelo Biosciences- Warrants (18/06/2024)'s ROE of -201.81% is lower than the Consumer Staples sector average of 14.41%. That is roughly 1500.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Artelo Biosciences- Warrants (18/06/2024)'s current -201.81% should be judged against Consumer Staples norms (sector average: 14.41%) and against ARTLW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -201.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 14.41%. From there, open related valuation or income-statement pages for Artelo Biosciences- Warrants (18/06/2024), and consider following ARTLW for alerts when major investors trade the stock.

Artelo Biosciences- Warrants (18/06/2024) is classified in the Consumer Staples sector. On ROE, it currently shows -201.81% versus a sector average near 14.41%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing ARTLW with unrelated industries.